Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-73.52	6.15	23.24
Graham Fair Price	41.54	0.07	0.05
PEG	-64.40	-0.09	0.26
Price/Book	-18.99	0.52	0.64
Price/Cash Flow	-61.50	0.58	1.51
Prices/Earnings	59.49	-9.18	-22.67
Price/Sales	-59.49	0.13	0.31
Price/FCF	-61.50	0.58	1.51
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.07	0.07
Operating Margin	0.00	< 0.005	< 0.005
ROA	-100.00	< 0.005	< 0.005
ROE	< 0.005	-0.01	-100.00
ROIC	< 0.005	< 0.005	63.74
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	< 0.005	-0.32	-99.28
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.98	-1.00	1.90
EPS QOQ	0.88	-1.00	13.79
FCF QOQ	1.79	1.10	-38.30
Revenue QOQ	-0.21	1.00	368.35
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	29.56	14.78	-50.00
Days Sales Outstanding (DSO)	32.77	19.86	-39.39
Inventory Turnover	3.04	6.09	100.00
Debt/Capitalization	0.58	0.58	0.10
Quick Ratio	0.94	1.00	6.12
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	0.12	0.12	0.08
Cash	0.21	0.21	0.08
Capex	< 0.005	< 0.005	-0.08
Free Cash Flow	0.05	0.10	110.58
Revenue	0.24	0.47	100.16
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.31	1.31	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.17	0.09	-46.14
Naive Interpretation	Member

06 - Financial Health · Weak

Rating